Progesterone analogs to reverse multidrug resistance

C - Chemistry – Metallurgy – 07 – J

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07J 41/00 (2006.01) A61K 31/57 (2006.01) A61K 31/575 (2006.01)

Patent

CA 2225712

The present invention is directed to novel progesterone derivatives, as well as to pharmaceutical compositions thereof, and methods of treatment using the derivatives. More particularly, the invention relates to C7-substituted derivatives of the pregnene series. The present invention is directed to methods of treating multidrug-resistant tumors, and especially breast tumors, with novel C7-substituted progesterone analogs.

Cette invention concerne de nouveaux dérivés de progestérone, leurs compositions pharmaceutiques et les méthodes de traitement dans lesquelles on utilise ces dérivés. L'invention concerne notamment les dérivés substitués en C7 de la série du pregnène. Cette invention concerne les méthodes de traitement de tumeurs à résistance multiple aux anticancéreux, et plus particulièrement dans le cas de tumeurs au sein, avec de nouveaux analogues de progestérone substitués en C7.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Progesterone analogs to reverse multidrug resistance does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Progesterone analogs to reverse multidrug resistance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Progesterone analogs to reverse multidrug resistance will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1844942

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.